Design, synthesis and biological evaluation of a series of novel pyrrolo[2,3-<em>d</em>]pyrimidin/pyrazolo[3,4-<em>d</em>]pyrimidin-4-amine derivatives as FGFRs-dominant multi-target receptor tyrosine kinase inhibitors for the treatment of gastric cancer

Publication date: October 2022Source: Bioorganic Chemistry, Volume 127Author(s): Xiuli Wu, Zhihao Liu, Cailin Gan, Wei Wei, Qianyu Zhang, Hongyao Liu, Hanyun Que, Xingping Su, Lin Yue, Hualong He, Liang Ouyang, Tinghong Ye